Mengeloglu, Z. Et Al. 2014. High Asymmetric Dimethylarginine (ADMA) Levels in Patients with Brucellosis. INFLAMMATION , vol.37, no.1 , 127-131.

Mengeloglu, Z., Sünnetçioğlu, M., Tosun, M., Kucukbayrak, A., CEYLAN, M. R., Baran, A. İ., ... Karahocagil, M.(2014). High Asymmetric Dimethylarginine (ADMA) Levels in Patients with Brucellosis. INFLAMMATION , vol.37, no.1, 127-131.

Mengeloglu, Zafer Et Al. "High Asymmetric Dimethylarginine (ADMA) Levels in Patients with Brucellosis," INFLAMMATION , vol.37, no.1, 127-131, 2014

Mengeloglu, Zafer Et Al. "High Asymmetric Dimethylarginine (ADMA) Levels in Patients with Brucellosis." INFLAMMATION , vol.37, no.1, pp.127-131, 2014

Mengeloglu, Z. Et Al. (2014) . "High Asymmetric Dimethylarginine (ADMA) Levels in Patients with Brucellosis." INFLAMMATION , vol.37, no.1, pp.127-131.

@article{article, author={Zafer Mengeloglu Et Al. }, title={High Asymmetric Dimethylarginine (ADMA) Levels in Patients with Brucellosis}, journal={INFLAMMATION}, year=2014, pages={127-131} }